1. X
  2. OncoAlert
Log inSign up
OncoAlert
123.2K posts
Image
user avatar
OncoAlert
@OncoAlert
🌐 Worldwide oncology professionals network | Run by oncologists, for colleagues | All tumor types | Non-profit 🚨 We are #OncoAlert | Oncology360°
Worldwide
OncoAlert360.com
Joined March 2019
137
Following
42.1K
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • Pinned
    user avatar
    OncoAlert
    @OncoAlert
    12h
    Does deeper HIF-2α suppression mean better outcomes in Refractory Clear Cell #KidneyCancer? We are here with another #WeekInOncology and no other than our faculty Natalia Gandur from Argentina🇦🇷 to guide us through this great publication Casdatifan shows durable response
    Image
    00:00
    1.4K01.4K
  • OncoAlert reposted
    user avatar
    Sophia Kamran, MD
    @Sophia_KamranMD
    13h
    Presenting our latest, just in time for the @NRGonc semiannual meeting: ascopubs.org/doi/10.1200/PO… 'Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology' 1/n
    Image
    ascopubs.org
    Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the...
    PURPOSEPrecision medicine has revolutionized oncology; however, tumor biomarkers are not reflective of the heterogeneous cancer population. We evaluated NRG Oncology prostate cancer (PCa) clinical...
    5840584
  • OncoAlert reposted
    user avatar
    ACS Journal Cancer
    @JournalCancer
    11h
    A focus on multimorbidity and a holistic, multidisciplinary, and patient-centered approach to address the challenge of common chronic diseases could significantly improve outcomes for patients with myelodysplastic syndrome. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert
    Image
    Excess risk for cardiovascular and noncardiovascular comorbidities and multimorbidity among...
    From acsjournals.onlinelibrary.wiley.com
    3630363
  • OncoAlert reposted
    user avatar
    Petros Grivas
    @PGrivasMDPhD
    11h
    Always great to hear @UrogerliMD discussing biomarkers in bladder cancer. Roger is excited about urine tumor DNA as complementary tool to plasma ctDNA!His talk was “groundbreaking” since we just experienced an earthquake but we are all safe! @BourlonMaite @ReginaBarCar @OncoAlert
    Image
    Image
    Image
    Image
    8220822
  • OncoAlert reposted
    user avatar
    European Urology Oncology
    @EurUrolOncol
    11h
    Recently published Letters to Editor! buff.ly/NgiegOL buff.ly/o96C1F2 buff.ly/ZQSktcI @Uroweb @MRoupret @GPloussard @jteoh_hk @Ric_Campi @CaPsurvivorship @LauraMarandino @RenuEapen @Ecastromarcos @OncoAlert @Sciencedirect
    Image
    00:00
    4670467
  • OncoAlert reposted
    user avatar
    CA: A Cancer Journal for Clinicians
    @CACancerJournal
    10h
    CA: A Cancer Journal for Clinicians is accepting proposals for high-impact Phase III trials that may inform standards of care. Accepted submissions may qualify for rapid review to align with conference proceedings. Learn more: acsjournals.onlinelibrary.wiley.com/doi/toc/10.332… @OncoAlert
    Image
    2540254
  • OncoAlert reposted
    user avatar
    ACS Journal Cancer
    @JournalCancer
    10h
    Administration of neoadjuvant chemotherapy for locally advanced colon cancer did not improve disease-free survival in comparison with upfront surgery according to results of a study published in JAMA Surgery. Read our CancerScope coverage: acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10… @OncoAlert
    Image
    3930393
  • OncoAlert reposted
    user avatar
    Oncology Brothers
    @OncBrothers
    6h
    This is the #algorithm we have used to discuss treating/risk stratifying newly diagnosed #MultipleMyeloma with @GKaurMD #HemeTwitter #OncTwitter #mmsm @OncUpdates @OncoAlert
    Image
    Image
    01:25
    user avatar
    Oncology Brothers
    @OncBrothers
    Jul 16
    Treatment Algorithm discussion on Smoldering Myeloma & NDMM w/ @GKaurMD ✅ Front line Rx ✅ Maintenance (see “ENDURANCE” trial) ✅ MRD Full 🗣️: ⭐️ oncbrothers.com/ndmm-smolderin… ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #HemeTwitter @OncUpdates @OncoAlert #mmsm
    1.2K01.2K
  • OncoAlert reposted
    user avatar
    Petros Grivas
    @PGrivasMDPhD
    11h
    Thrilled to present rapidly evolving field of ctDNA data in bladder cancer in Acapulco, Mexico!Great discussion & opportunity to practice my Spanish :-) @UrogerliMD @ReginaBarCar @BourlonMaite @fredhutch @OncoAlert @nataliagandur @DrOmarMian @spsutkaMD @UroDocAsh @SpiessPhilippe
    Image
    Image
    Image
    Image
    9810981
  • OncoAlert reposted
    user avatar
    OncoAlert
    @OncoAlert
    Jul 16
    Tucatinib in Combination With Trastuzumab Deruxtecan in Patients With Previously Treated HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer: An Open-Label Phase 2 Study buff.ly/TYvxbJO The phase 2 HER2CLIMB-04 trial evaluated tucatinib plus trastuzumab
    Image
    1.4K01.4K
  • OncoAlert reposted
    user avatar
    OncoAlert
    @OncoAlert
    Jul 16
    NEWS FROM INDUSTRY: KEYNOTE-C93 Update in #EndometrialCancer Source: Merck press release The Phase 3 KEYNOTE-C93 trial showed pembrolizumab monotherapy significantly improved progression-free survival compared with platinum-based chemotherapy in patients with previously
    Image
    2.7K02.7K
  • OncoAlert reposted
    user avatar
    Aya Mohamed | MSc, MD 🎗
    @Dr_Oncologista
    12h
    After the 15-year SOFT/TEXT results, what is your preferred approach for high-risk premenopausal HR+/HER2− early breast cancer? @OncoAlert #BreastCancer #bcsm #OncoPoll

    When you make a selection it cannot be changed

    45 votes12h left
    1.1K01.1K
  • OncoAlert reposted
    user avatar
    Andrea Necchi, MD, FASCO
    @AndreaNecchi
    13h
    #ESMO26 abstract titles are released online. The readout of 2 big randomized Ph3 studies of perioperative chemoIO in MIBC is planned in Proffered Paper Session 2, stay tuned! #ENERGIZE @myESMO @IBCG_BladderCA @OncoAlert @urotoday @SanRaffaeleMI @MyUniSR @Larvol @sonpavde
    Image
    7510751
  • OncoAlert reposted
    user avatar
    Mirrors of Medicine
    @mirrorsmed
    17h
    Are we doing too many prostate biopsies? A simple metric may help identify who truly needs systematic sampling. The utility of PSA density for selection of targeted versus systematic transperineal prostate biopsy: A retrospective cohort study
    Image
    bjui-journals.onlinelibrary.wiley.com
    The utility of PSA density for selection of targeted versus systematic transperineal prostate...
    Objectives The objective of this study is to evaluate PSA density (PSAD) as an adjunctive predictor of prostate cancer (PCa) detection on magnetic resonance imaging (MRI)-guided transperineal...
    4340434
Advertisement
Advertisement